Skip to content
ClinCalc Pro
Menu
Vital Dye — Ocular Surface Staining (Dry Eye Diagnosis)

Lissamine Green 1% Eye Drops

Brand names: Lissamine Green Ophthalmic Solution

Lissamine green is an ophthalmic diagnostic dye applied to the eye to assess the health of the ocular surface, particularly in dry eye disease.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It stains devitalised and degenerate epithelial cells and areas of the cornea and conjunctiva lacking an adequate protective mucin coating, highlighting ocular surface damage for examination.

Prescribing in practice

  • It is a diagnostic agent for clinician-applied ocular surface examination, not a treatment, and should be instilled and interpreted by a trained eye care professional.
  • It is generally well tolerated and causes less stinging than rose bengal, making it useful for ocular surface staining.
  • Examine the stained ocular surface promptly after application as staining is assessed during slit-lamp evaluation.

Monitoring

No ongoing monitoring is required as it is used once at the point of clinical assessment of the ocular surface.

Counselling the patient

  • Explain that a harmless coloured dye is being placed in the eye to check the surface during examination.
  • Mild transient irritation may occur but settles quickly after the examination.

Evidence & guidelines

Lissamine green staining is a standard component of ocular surface assessment in dry eye disease evaluation in ophthalmic practice.

Reference: TFOS DEWS II Diagnostic Methodology Report (Ocul Surf 2017); van Bijsterveld OP, Arch Ophthalmol 1969; SPC Lissamine Green Ophthalmic; NICE TA369; Confirm identity and dosing against the manufacturer SPC (eMC) and NICE. Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.